Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: FIGO STAGE, . Treffer: 32

2018

Petru, E; Huber, C; Sampl, E; Haas, J Comparison of Primary Tumor Size in Stage I and III Epithelial Ovarian Cancer.
Anticancer Res. 2018; 38(11):6507-6511
Web of Science PubMed FullText FullText_MUG

 

2016

Schwameis, R; Grimm, C; Brodowicz, T; Petru, E; Hefler-Frischmuth, K; Staudigl, C; Reinthaller, A; Heinze, G; Polterauer, S; Polterauer, M Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma.
Sci Rep. 2016; 6(5):33757-33757 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Tahmasbi Rad, M; Wallwiener, M; Schemmer, P; Schott, S; Sohn, C; Rom, J; Eichbaum, M Laparoscopically assisted vaginal hysterectomy in a patient with micro-invasive cervical cancer after two liver transplantations.
J Obstet Gynaecol Can. 2012; 34(4):363-366 (- Case Report)
PubMed

 

2011

Greimel, E; Daghofer, F; Petru, E Prospective assessment of quality of life in long-term ovarian cancer survivors.
Int J Cancer. 2011; 128(12): 3005-3011. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Auner, V; Kriegshäuser, G; Tong, D; Horvat, R; Reinthaller, A; Mustea, A; Zeillinger, R KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.
BMC Cancer. 2009; 9(1): 111-111. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Petru, E; Benedicic, C; Kimmig, R; Marth, C Early ovarian cancer (FIGO stage I-IIA)
ONKOLOGE. 2008; 14(11): 1130-+.
Web of Science FullText FullText_MUG

 

2007

Bader, AA; Petru, E; Winter, R Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy.
Gynecol Oncol. 2007; 105(1):269-272 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Hilpert, F; du Bois, A; Greimel, E; Hedderich, J; Krause, G; Venhoff, L; Loibl, S; Pfisterer, J Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany.
Ann Oncol. 2007; 18(2): 282-287. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scholz, HS; Tasdemir, H; Hunlich, T; Turnwald, W; Both, A; Egger, H Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: results and 5-year follow-up.
Gynecol Oncol. 2007; 106(3): 591-595.
Web of Science PubMed FullText FullText_MUG

 

2006

Bader, AA; Bjelic-Radisic, V; Tamussino, KF; Pristauz, G; Winter, R Recurrence in a Schuchardt incision after Schauta-Amreich radical vaginal hysterectomy for cervical cancer.
Int J Gynecol Cancer. 2006; 16(3):1479-1481 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Marth, C; Windbichler, GH; Hausmaninger, H; Petru, E; Estermann, K; Pelzer, A; Mueller-Holzner, E Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study.
Int J Gynecol Cancer. 2006; 16(4): 1522-1528.
Web of Science PubMed FullText FullText_MUG

 

2005

Kapp, KS; Poschauko, J; Tauss, J; Berghold, A; Oechs, A; Lahousen, M; Petru, E; Winter, R; Kapp, DS Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Int J Radiat Oncol Biol Phys. 2005; 62(5):1399-1404
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Reich, O; Pürstner, P; Klaritsch, P; Haas, J; Lahousen, M; Tamussino, K; Winter, R Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer.
Eur J Gynaecol Oncol. 2003; 24(1):13-17
Web of Science PubMed Google Scholar

 

Scholz, HS; Lax, SF; Benedicic, C; Tamussino, K; Winter, R Accuracy of frozen section examination of pelvic lymph nodes in patients with FIGO stage IB1 to IIB cervical cancer.
Gynecol Oncol. 2003; 90(3):605-609
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Scholz, HS; Benedicic, C; Haas, J; Tamussino, K; Petru, E Stage IV ovarian cancer: prognostic factors and survival beyond 5 years.
ANTICANCER RES. 2002; 21(5): 3729-3732.
Web of Science PubMed

 

2001

Grote, HJ; Friedrichs, N; Pomjanski, N; Guhde, HF; Reich, O; Böcking, A Prognostic significance of DNA cytometry in carcinoma of the uterine cervix FIGO stage IB and II.
Anal Cell Pathol. 2001; 23(3-4):97-105 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Scholz, HS; Petru, E; Gücer, F; Haas, J; Tamussino, K; Winter, R Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
ANTICANCER RES. 2001; 20(5C): 3983-3985.
Web of Science PubMed

 

Tamussino, KF; Gücer, F; Reich, O; Moser, F; Petru, E; Scholz, HS Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma.
Int J Gynecol Cancer. 2001; 11(3):236-240
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Reich, O; Tamussino, K; Lahousen, M; Pickel, H; Haas, J; Winter, R Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
Gynecol Oncol. 2000; 76(3):331-335
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Rosen, AC; Klein, M; Hafner, E; Lahousen, M; Graf, AH; Reiner, A Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.
GYNECOL OBSTET INVEST. 1999; 47(1): 45-51.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Kapp, KS; Stuecklschweiger, GF; Kapp, DS; Poschauko, J; Pickel, H; Lahousen, M; Hackl, A Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
Int J Radiat Oncol Biol Phys. 1998; 42(3):531-540
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Petru, E; Nagele, F; Czerwenka, K; Graf, AH; Lax, S; Bauer, M; Pehamberger, H; Vavra, N Primary malignant melanoma of the vagina: long-term remission following radiation therapy.
Gynecol Oncol. 1998; 70(1):23-26
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Rosen, AC; Ausch, C; Hafner, E; Klein, M; Lahousen, M; Graf, AH; Reiner, A A 15-year overview of management and prognosis in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.
Eur J Cancer. 1998; 34(11):1725-1729
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Kapp, KS; Stuecklschweiger, GF; Kapp, DS; Poschauko, J; Pickel, H; Hackl, A Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy.
Radiother Oncol. 1997; 42(2):143-153
Web of Science PubMed FullText FullText_MUG

 

1995

Nagele, F; Petru, E; Medl, M; Kainz, C; Graf, AH; Sevelda, P Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer.
Obstet Gynecol. 1995; 86(2):259-264
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1994

Rosen, AC; Graf, AH; Klein, M; Lahousen, M; Vavra, N; Reiner, A; Hacker, GW DNA ploidy in primary fallopian-tube carcinoma using image cytometry.
Int J Cancer. 1994; 58(3):362-365
Web of Science PubMed FullText FullText_MUG

 

Rosen, AC; Klein, M; Rosen, HR; Graf, AH; Lahousen, M; Reiner, A; Vavra, N; Auerbach, L Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinoma.
Arch Gynecol Obstet. 1994; 255(2):65-68
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1993

Girardi, F; Petru, E; Heydarfadai, M; Haas, J; Winter, R Pelvic lymphadenectomy in the surgical treatment of endometrial cancer.
Gynecol Oncol. 1993; 49(2):177-180
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Girardi, F; Pickel, H; Beyer-Finkler, E; Pfister, H Specific rearrangements of human papillomavirus DNA provide molecular evidence for genetic heterogeneity of primary cervical cancers, recurrencies, and lymph node metastases in two patients.
Gynecol Oncol. 1993; 51(2):281-286 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Marth, C; Weger, A; Müller-Holzner, E; Zeimet, AG; Moncayo-Naveda, H; Daxenbichler, G; Reibnegger, G; Fuchs, D; Wachter, H; Dapunt, O The prognostic value of nuclear roundness and neopterin in ovarian cancer.
Eur J Cancer. 1993; 29A(13):1863-1868
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Arian-Schad, KS; Kapp, DS; Hackl, A; Juettner, FM; Leitner, H; Porsch, G; Lahousen, M; Pickel, H Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary report.
Gynecol Oncol. 1990; 39(1):47-55
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1989

Auner, H; Petru, E; Hofmann, HM; Pickel, H; Pürstner, P In vitro chemosensitivity testing in the treatment of ovarian carcinoma.
Arch Gynecol Obstet. 1989; 246(4):227-231
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum